60 DEGREES PHARMACEUTICALS, INC. - 8-K Filing
60 Degrees Pharmaceuticals submitted a Statement of Interest for an FDA Commissioner’s National Priority Voucher to support approval of ARAKODA® (tafenoquine) for babesiosis. (Items: 8.01 Other Events)
Tickers: $SXTP